What to expect when you take Solu-medrol and have Colitis microscopic?

Do you take Solu-medrol and have Colitis microscopic? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and find Care Guides.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Sep, 21, 2018

6,075 reports have been studied.


Females aged 50 to 59 :

3,316 related reports were analyzed:

Most common symptoms:

Cough
  • 5.07% for females aged 50 (±5) who take Solu-medrol
Diarrhea
  • 6.09% for females aged 50 (±5) who take Solu-medrol
Drug ineffective
  • 6.24% for females aged 50 (±5) who take Solu-medrol
Dyspnea
  • 7.09% for females aged 50 (±5) who take Solu-medrol
Fatigue
  • 6.39% for females aged 50 (±5) who take Solu-medrol
Fever
  • 9.2% for females aged 50 (±5) who take Solu-medrol
Headache
  • 6.54% for females aged 50 (±5) who take Solu-medrol
High blood pressure
  • 7.0% for females aged 50 (±5) who take Solu-medrol
Hypotension
  • 5.79% for females aged 50 (±5) who take Solu-medrol
Infusion related reaction
  • 7.63% for females aged 50 (±5) who take Solu-medrol
Joint pain
  • 7.09% for females aged 50 (±5) who take Solu-medrol
Nausea
  • 9.32% for females aged 50 (±5) who take Solu-medrol
Nausea and vomiting
  • 5.64% for females aged 50 (±5) who take Solu-medrol
Pain
  • 7.72% for females aged 50 (±5) who take Solu-medrol
Rashes
  • 8.2% for females aged 50 (±5) who take Solu-medrol
Stress and anxiety
  • 5.1% for females aged 50 (±5) who take Solu-medrol
Thrombocytopenia
  • 5.04% for females aged 50 (±5) who take Solu-medrol
Weakness
  • 5.1% for females aged 50 (±5) who take Solu-medrol

Most common co-existing conditions:

Rheumatoid arthritis
  • 16.16% for females aged 50 (±5) who take Solu-medrol
back to top

Males aged 50 to 59 :

2,759 related reports were analyzed:

Most common symptoms:

Dyspnea
  • 5.84% for males aged 50 (±5) who take Solu-medrol
Fever
  • 8.26% for males aged 50 (±5) who take Solu-medrol
Hypotension
  • 5.44% for males aged 50 (±5) who take Solu-medrol
Pneumonia
  • 6.09% for males aged 50 (±5) who take Solu-medrol
Thrombocytopenia
  • 6.92% for males aged 50 (±5) who take Solu-medrol

Most common co-existing conditions:

Kidney transplant
  • 5.15% for males aged 50 (±5) who take Solu-medrol
back to top

Related studies

solu-medrol

Solu-medrol has active ingredients of methylprednisolone sodium succinate. It is often used in multiple sclerosis. (latest outcomes from Solu-medrol 23,862 users)

colitis microscopic

Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps) has been reported by people with rheumatoid arthritis, high blood pressure, depression, gastroesophageal reflux disease, osteoporosis (latest reports from 2,157 Colitis microscopic patients).

Solu-medrol and Colitis microscopic

Analysis tools (to study 506 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Solu-medrol, Colitis microscopic

Recent updates

General studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.